Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Integrity Oncology PLLC-Collierville
mi
from
Collierville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
UM Sylvester Comprehensive Cancer Center at Deerfield Beach
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Walter Knox Memorial Hospital
mi
from
Emmett, ID
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Genesee Hematology Oncology PC
mi
from
Flint, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Regional Cancer Center-Lee Memorial Health System
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Michigan Breast Specialists-Grosse Pointe Woods
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
UM Sylvester Comprehensive Cancer Center at Hollywood
mi
from
Hollywood, FL
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Hawaii Cancer Care Inc-Liliha
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
ProHealth D N Greenwald Center
mi
from
Mukwonago, WI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
ProHealth Oconomowoc Memorial Hospital
mi
from
Oconomowoc, WI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
University of Chicago Medicine-Orland Park
mi
from
Orland Park, IL
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Oncology Hematology Associates of Saginaw Valley PC
mi
from
Saginaw, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Saint Mary's Oncology/Hematology Associates of West Branch
mi
from
West Branch, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Fairview Lakes Medical Center
mi
from
Wyoming, MN
Click here to add this to my saved trials
Atopy Clinical Trial
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK001
Status: Enrolling, Phase I
Updated: 9/28/2015
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
Thromboembolism Clinical Trial
Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates
Status: Enrolling, Phase I, II
Updated: 12/21/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Chermside,
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Dietary Modification Clinical Trial
COntinuous vs BOlus Nasogastric Feeding in Mechanically Ventilated Pediatric Patients 2
Status: Enrolling
Updated: 1/18/2018
Shands Children's Hospital
mi
from
Gainesville, FL
Click here to add this to my saved trials
Clinical Trial
Cisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor M6620 in Treating Patients With Metastatic Urothelial Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada-Horizon Ridge
mi
from
Henderson, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
OptumCare Cancer Care at Oakey
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Rockwood North Cancer Treatment Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Promedica Flower Hospital
mi
from
Sylvania, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Impact of CD34+ Cell Dose on Progression-free Survival Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Beverly, MA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Fort Gratiot, MI
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Onalespib in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Nebraska Medicine-Village Pointe
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Austin Cancer Centers /ID# 151061
mi
from
Austin, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Tufts Medical Center /ID# 145897
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling, Phase II, III
Updated: 12/31/1969
MD Anderson Cancer Center at Cooper /ID# 145891
mi
from
Camden, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Cleveland Clinic Foundation /ID# 144023
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Wayne State University /ID# 145890
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Highlands Oncology Group /ID# 142050
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Penn State Univ and Milton S. Hershey Medical Center /ID# 147525
mi
from
Hershey, PA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics /ID# 144167
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Baptist Hospital Miami /ID# 152451
mi
from
Miami, FL
Click here to add this to my saved trials
Primary Uterine Infertility Clinical Trial
Uterine Transplantation for the Treatment of Uterine Factor Infertility
Status: Enrolling, Phase I
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
Western Regional Medical Center at Cancer Treatment Centers of America
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
Advocate Medical Group - Park Ridge, Luther Lane - Oncology
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Solid Tumors Habouring NTRK Fusion Clinical Trial
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
UCLA-Santa Monica Medical Center
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Children's Heathcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondandsetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)
Status: Enrolling, Phase III
Updated: 7/28/2016
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
St. Vincent Anderson Regional Hospital
mi
from
Anderson, IN
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Grady Clinical Research Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Hematology Oncology Physicians of Englewood, PA
mi
from
Englewood, NJ
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Rocky Mountain Cancer Centers, LLP- Littleton
mi
from
Littleton, CO
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology-McKinney
mi
from
McKinney, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
University Cancer Institute, LLC
mi
from
Monroeville, PA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Christus Cancer Treatment Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Arizona Oncology Associates, PC - HAL-Scottsdale
mi
from
Tempe, AZ
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Rocky Mountain Cancer Centers, LLP- Thornton
mi
from
Thornton, CO
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Compass Oncology Tualatin
mi
from
Tualatin, OR
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology, P.A. - Horizon Circle
mi
from
Waco, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
St Elizabeth Hospital
mi
from
Youngstown, OH
Click here to add this to my saved trials
Cleft Palate Clinical Trial
Improving Outcomes in Cleft Palate Surgery
Status: Enrolling
Updated: 10/20/2015
London Health Science Center
mi
from
London,
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Feasibility Study of a Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
HIV Prevention Clinical Trial
Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women
Status: Enrolling, Phase IV
Updated: 2/7/2018
T.H.E. at Ruth Temple
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Illinois at Chicago, Department of Ophthalmology (MC 648)
mi
from
Chicago, IL
Click here to add this to my saved trials
Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Houston Methodist Hospital, Blanton Eye Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
NeuroEyeOrbit Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Sydney Eye Hospital/Save Sight Institute
mi
from
Sydney,
Click here to add this to my saved trials
Pulmonary Embolism Clinical Trial
Predicting the Safety and Effectiveness of Inferior Vena Cava Filters
Status: Enrolling, Phase
Updated: 12/31/1969
Medical College of WI/Froedtert Memorial Lutheran Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Pulmonary Embolism Clinical Trial
Predicting the Safety and Effectiveness of Inferior Vena Cava Filters
Status: Enrolling, Phase
Updated: 12/31/1969
Oregon Health and Science Center
mi
from
Portland, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Palmetto Health, USC School of Medicine
mi
from
Columbia, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Royal North Shore Hospital
mi
from
Sydney,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Los Angeles Biomedical Research Center at Harbor- UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer.
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Seoul,
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
mi
from
St. Cloud, MN
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
mi
from
West Hartford, CT
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Children's Hospital- Clinical Research Center
mi
from
Houston, TX
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling, Phase III
Updated: 12/31/1969
Pediatric Specialty Care Explorer Clinic, University of Minnesota Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling, Phase III
Updated: 12/31/1969
Journey Clinic: Center for Children with Cancer and Blood Diseases, Uni. of Minnesota Medical Centre
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling, Phase III
Updated: 12/31/1969
PCH Pharmacy - Primary Children's Hospital - Pharmacy
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials